Pharmacyclics Inc. (PCYC), a developer of cancer treatments, is considering a sale and has attracted interest from potential suitors including Johnson & Johnson (JNJ) and Novartis AG (NVS), Bloomberg News reported Wednesday, citing people with knowledge of the matter.

The company's shares were recently up 19% to $224.32.

Full story at: www.bloomberg.com/news/articles/2015-02-25/pharmacyclics-said-to-weigh-sale-of-15-billion-u-s-drugmaker

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Johnson and Johnson Charts.